Influência da abordagem nutricional e clínica do tratamento da obesidade na relação Firmicutes e Bacteroidetes da microbiota intestinal em adolescentes
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Obesity is a multifactorial problem that is increasingly prevalent today, particularly among
younger individuals due to specific characteristics of this group. This health issue originates
from an imbalance between calorie intake and expenditure, but is also influenced by various
factors such as genetic predisposition, insulin resistance, behavioral, nutritional,
biochemical, social variables, and, as some studies suggest, the microbiological composition
of individuals. These studies indicate that the gut microbiota is closely connected with the
health of its hosts, affecting various biological, neurological, inflammatory, and pathogenic
processes. It has been identified that the Firmicutes and Bacteroidetes phyla and the ratio
between them may be relevant and correlated with the prevalence of this comorbidity. With
the aid of biochemical tests and the collection of behavioral and nutritional data, appropriate
nutritional follow-up emerges as an alternative for treating this comorbidity. An effective
approach can prevent nutritional deficiencies and excessive food intake, as well as encourage
a varied diet with different groups of fresh and minimally processed foods, promoting
healthy eating habits and behaviors, thereby improving several indicators associated with
obesity. This study assessed the impact of nutritional follow-up on clinical indicators for
obesity control in adolescent patients and the correlation with changes in microbiota through
the measurement of the Firmicutes/Bacteroidetes ratio in fecal metagenome. Out of 35
individuals in the sample, 12 completed all stages of the 6-month longitudinal study. Data
collected from clinical and laboratory follow-ups indicate that despite improvements in the
average BMI (from 31.7 to 29.6) and diet quality, with significant changes in carbohydrate
intake (from 50.6% to 55.7%) and reduction in lipid intake (from 25.9% to 20.6%), there
were no significant changes in most clinical indicators, with only a notable reduction in the
HOMA Beta index from 413.2 to 286.6 during the analyzed period, reflecting improved
insulin secretion by the pancreas. The variation in the average Firmicutes/Bacteroidetes ratio
between assessments was small but relevant, from 3.02 to 1.89. Through multiple
correspondence analysis, it was noted that although the global change in microbiota and
calorie intake did not follow a clustering pattern, all other parameters correlated positively
with participant progress during the study period. However, the Firmicutes/Bacteroidetes
ratio had little influence or relevance on the clinical outcome, suggesting that this microbiota
ratio was not an adequate marker for measuring, relating, or stratifying clinical success in
this study compared to other biochemical or nutritional markers. These findings may assist
in treating obesity in younger individuals but also highlight that further research with this
participant profile needs to be more thoroughly explored, given the specific biochemical,
microbiological, social, and anthropometric characteristics of this population.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

